Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifaximin Therapy Versus Low FODMAP Diet In Irritable Bowel Syndrome: A Randomised Controlled Trial

NCT04841980 is registered in ClinicalTrials.gov with University of Malaya as lead sponsor.

NCT NCT04841980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04841980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifaximin Therapy Versus Low FODMAP Diet In Irritable Bowel Syndrome: A Randomised Controlled Trial
Lead sponsor
University of Malaya
Phase
Phase 4
Overall status
Unknown status
Start date
April 22, 2021
Completion date
May 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, small intestinal bacterial overgrowth